LBA7 Efficacy and safety of datopotamab deruxtecan (Dato-DXd) in patients (pts) with previously-treated EGFR-mutated advanced non-small cell lung cancer (NSCLC): A pooled analysis of TROPION-Lung01 and TROPION-Lung05M-J. Ahn, Weili Gu, Jacob Sands et al.|Annals of Oncology|2024Cited by 9
P3.18.39 PRESERVE-003: A Phase 3 Study of Gotistobart Versus Docetaxel in Metastatic NSCLC After Progression on PD-(L)1 InhibitorsTengfei Li, Mark A. Socinski, Hsin‐Jen Chen et al.|Journal of Thoracic Oncology|2025Cited by 1